2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
13126
Triple Negative Breast Neoplasms
1148
Neoplasms
749
Ovarian Neoplasms
680
Neoplasm Metastasis
590
Lung Neoplasms
582
Colorectal Neoplasms
579
Prostatic Neoplasms
559
Carcinoma, Non-Small-Cell Lung
534
Pancreatic Neoplasms
380
Melanoma
366
Stomach Neoplasms
350
Colonic Neoplasms
330
Motor Activity
285
Breast Neoplasms, Male
285
Carcinoma, Intraductal, Noninfiltrating
277
Uterine Cervical Neoplasms
266
Head and Neck Neoplasms
266
Endometrial Neoplasms
256
Carcinoma, Renal Cell
216
Sarcoma
203
Urinary Bladder Neoplasms
192
Squamous Cell Carcinoma of Head and Neck
191
Lymphedema
190
Esophageal Neoplasms
189
Breast Carcinoma In Situ
189
Brain Neoplasms
183
Fatigue
166
Carcinoma, Ovarian Epithelial
151
Breast Cancer Female
148
Interventions
tucatinib
1
pertuzumab
1
Trastuzumab
1
Biosimilar Pharmaceuticals
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metastatic Breast Cancer With a Isolated Brain Progression
×
Breast
×
Clear all
NCT05041842
2025-11-17
InTTercePT
UNICANCER
Phase 2
Active not recruiting
53 enrolled